{"id":408364,"date":"2021-01-05T08:03:27","date_gmt":"2021-01-05T13:03:27","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408364"},"modified":"2021-01-05T08:03:27","modified_gmt":"2021-01-05T13:03:27","slug":"azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/","title":{"rendered":"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">DELRAY BEACH, Fla., Jan.  05, 2021  (GLOBE NEWSWIRE) &#8212; AzurRx BioPharma, Inc. (NASDAQ: AZRX), (\u201cAzurRx\u201d or the \u201cCompany\u201d), a company specializing in the development of targeted, non-systemic\u00a0therapies for\u00a0gastrointestinal (GI) diseases, today announced that the Company will participate in the 10<sup>th<\/sup> Annual LifeSci Partners Corporate Access Event.<\/p>\n<p align=\"justify\">James Sapirstein, President &amp; CEO of AzurRx BioPharma will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. Mr. Sapirstein will be available to provide an overview of the Company\u2019s business and clinical development programs and discuss anticipated 2021 milestones.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:8%;width:8%;min-width:8%\">\n            <strong>Event:<\/strong>\n          <\/td>\n<td style=\"max-width:92%;width:92%;min-width:92%\">10<sup>th<\/sup> Annual LifeSci Partners Corporate Access Event<\/td>\n<\/tr>\n<tr>\n<td>\n            <strong>Dates:<\/strong>\n          <\/td>\n<td>January 6-8 &amp; 11-14, 2021<\/td>\n<\/tr>\n<tr>\n<td>\n            <strong>Registration:<\/strong>\n          <\/td>\n<td>\n            <a href=\"https:\/\/www.lifesciadvisors.com\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.lifesciadvisors.com<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong>About AzurRx BioPharma, Inc.<br \/><\/strong>AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a clinical stage biopharmaceutical company\u00a0specializing\u00a0in the development of targeted, non-systemic therapies for\u00a0gastrointestinal (GI) diseases. The Company has a pipeline of three gut-restricted GI assets: MS1819 \u2013 a recombinant lipase biologic for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis \u2013 with two ongoing Phase 2\u00a0clinical trials; and two clinical-stage therapies using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor;\u00a0 FW-420, for the treatment of grade 1 Immune Checkpoint Inhibitor Associated Colitis (ICI-AC) and diarrhea in oncology patients and FW-1022, for the treatment of COVID-19 gastrointestinal infections. The Company is headquartered in Delray Beach, Florida with clinical operations in Hayward, California. Additional information on the Company can be found at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a0COF0JTKD_dR7DtgMLz6w1z1M_lRbcPxVzoFEymbQF5aI5w10ItqCWeTrviBNUWydqe2Wa7U7KU1eOuc-4PHQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.azurrx.com<\/a>.<\/p>\n<p>\n        <strong><br \/>\n          <em>For more information:<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>AzurRx BioPharma, Inc.<br \/>1615 South Congress Avenue<br \/>Suite 103<br \/>Delray Beach, Florida 33445<br \/>Phone: (646) 699-7855<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0UqVKQKNCBv9JivPGTglNz5hpwB-NFdGbY7LGDjyRTzuqtvb3TIhvYIBw_6lWJP9aqlPnMFk_0mDNxjBups85A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@azurrx.com<\/a><\/p>\n<p>\n        <strong>Investor Relations contact:<\/strong>\n      <\/p>\n<p>LifeSci Advisors, LLC.\u00a0<br \/>Hans Vitzthum, Managing Director\u00a0<br \/>1 International Place, Suite 1480\u00a0<br \/>Boston, MA 02110\u00a0<br \/>Phone: (617) 430-7578\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BCgOGFMyIzee-nFeGtDnUWmXSphgNM2uPTnZfvWLTL-9w_rLVdxSlOsqjS_rApG7jVK0w5jafGuJZBh__BdR0BF21QqY-2tdOTQon833V5o=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">hans@lifesciadvisors.com<\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/bc946983-8fa7-4548-980b-edd9bcd735be\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DELRAY BEACH, Fla., Jan. 05, 2021 (GLOBE NEWSWIRE) &#8212; AzurRx BioPharma, Inc. (NASDAQ: AZRX), (\u201cAzurRx\u201d or the \u201cCompany\u201d), a company specializing in the development of targeted, non-systemic\u00a0therapies for\u00a0gastrointestinal (GI) diseases, today announced that the Company will participate in the 10th Annual LifeSci Partners Corporate Access Event. James Sapirstein, President &amp; CEO of AzurRx BioPharma will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. Mr. Sapirstein will be available to provide an overview of the Company\u2019s business and clinical development programs and discuss anticipated 2021 milestones. Event: 10th Annual LifeSci Partners Corporate Access Event Dates: January 6-8 &amp; 11-14, 2021 Registration: www.lifesciadvisors.com About AzurRx BioPharma, Inc.AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a clinical stage biopharmaceutical company\u00a0specializing\u00a0in the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408364","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DELRAY BEACH, Fla., Jan. 05, 2021 (GLOBE NEWSWIRE) &#8212; AzurRx BioPharma, Inc. (NASDAQ: AZRX), (\u201cAzurRx\u201d or the \u201cCompany\u201d), a company specializing in the development of targeted, non-systemic\u00a0therapies for\u00a0gastrointestinal (GI) diseases, today announced that the Company will participate in the 10th Annual LifeSci Partners Corporate Access Event. James Sapirstein, President &amp; CEO of AzurRx BioPharma will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. Mr. Sapirstein will be available to provide an overview of the Company\u2019s business and clinical development programs and discuss anticipated 2021 milestones. Event: 10th Annual LifeSci Partners Corporate Access Event Dates: January 6-8 &amp; 11-14, 2021 Registration: www.lifesciadvisors.com About AzurRx BioPharma, Inc.AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a clinical stage biopharmaceutical company\u00a0specializing\u00a0in the &hellip; Continue reading &quot;AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T13:03:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event\",\"datePublished\":\"2021-01-05T13:03:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/\"},\"wordCount\":284,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/\",\"name\":\"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc=\",\"datePublished\":\"2021-01-05T13:03:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/","og_locale":"en_US","og_type":"article","og_title":"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event - Market Newsdesk","og_description":"DELRAY BEACH, Fla., Jan. 05, 2021 (GLOBE NEWSWIRE) &#8212; AzurRx BioPharma, Inc. (NASDAQ: AZRX), (\u201cAzurRx\u201d or the \u201cCompany\u201d), a company specializing in the development of targeted, non-systemic\u00a0therapies for\u00a0gastrointestinal (GI) diseases, today announced that the Company will participate in the 10th Annual LifeSci Partners Corporate Access Event. James Sapirstein, President &amp; CEO of AzurRx BioPharma will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. Mr. Sapirstein will be available to provide an overview of the Company\u2019s business and clinical development programs and discuss anticipated 2021 milestones. Event: 10th Annual LifeSci Partners Corporate Access Event Dates: January 6-8 &amp; 11-14, 2021 Registration: www.lifesciadvisors.com About AzurRx BioPharma, Inc.AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a clinical stage biopharmaceutical company\u00a0specializing\u00a0in the &hellip; Continue reading \"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T13:03:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event","datePublished":"2021-01-05T13:03:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/"},"wordCount":284,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/","name":"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc=","datePublished":"2021-01-05T13:03:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDQ5NyMzOTA0NDQ0IzIwODIyMDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-10th-annual-lifesci-partners-corporate-access-event\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408364"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408364\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}